Algorithms

12 Million

Patients worldwide

Unlock access to rare patients with AI-based technology

Saventic Health helps you streamline clinical trials, diagnostics, and treatment pathways for rare diseases. Our AI-driven technology identifies high-risk patients faster and more accurately, allowing you to accelerate recruitment, reduce diagnostic delays, and improve outcomes.

Whether you’re running clinical studies or expanding access to therapies, we support your goals by making the patient journey more efficient—from suspicion to confirmed diagnosis and beyond.

Saventic Med

Integration with hospitals EMRs, analysis of all clinical data and identification of high risk patients.

Saventic Care

Global, online application for patients, caregivers and GPs to identify high risk patients and organise the entire journey.

500+

Rare-disease diagnosis

Our presence

We have active projects and strategic partnerships in countries across South America, North America, Asia, and Europe, including:

South America: Argentina, Brazil, Chile, Colombia

North America: Canada, Mexico, United States

Asia: Taiwan

Europe: Austria, France, Germany, Poland, Switzerland

Additionally, we have plans to expand to more countries in Latin America, Asia, and the Gulf region.

Canada, Calgary

USA, Boston

Colombia, Bogotá

Brazil, Sao Paulo

Poland / CEE, Warsaw

Germany, Leipzig / Berlin

Our focus on rare diseases

300 million people live with a rare disease worldwide, but they are still overlooked. Most healthcare professionals are not familiar with these conditions, misdiagnosing patients with other diseases due similar symptoms.

On top of that, the lack of scalable tools able to flag early signs and refer patients accordingly contributes to a poor funnel.

As a result, most rare patients wait over 5 years for a diagnosis confirmation. During this time, their symptoms can get worse, sometimes even permanent. This issue also impacts the public health system, private institutions and patients' families financially. Every year, the US Government spends $266.000 per patient on medical costs.

The sooner we get a diagnosis, the earlier we can reduce the burden for everyone involved in the patients journey - and contribute to a better life quality.

Key facts

6-8%

of the global population live with a rare disease.

7000+

rare diseases have been identified by science.

50%

of rare diseases affect children, many with early-onset, life-limiting conditions.

1 in 8

patients with rare diseases actually receive a diagnosis; most spend their lives without a final answer.

years on average is the diagnostic delay faced by most rare disease patients.

10%

of rare diseases currently have a treatment, though many players are actively developing new therapies.

Current focus

Our algorithms focus on rare diseases with systemic impacts — including hematologic, immunologic, metabolic, and cardiovascular conditions — where early detection is critical and symptoms are often nonspecific.

Blood and bone marrow diseases

Blood cancers (various including, mastocytosis and myelofibrosis)
CTCL
PNH
Castleman (iMCD)
ITP
HLH
MDS
Waldenström macroglobulinemia
TMA

Immune System

Common variable immunodeficiency (CVID)
Severe combined immunodeficency (SCID)
DiGeorge syndrome
Chronic granumolatus disease (CGD)
Hereditary Angioedema (HAE)

Metabolic Diseases

Gaucher disease
Fabry disease
Pompe disease
MPS 1
MPS 2 (Hunter)
MPS 3
HPP

Others

Amylodosis AL
Amylodosis ATTR
Post-Stroke Spasticity
Hypercholesterolemia
Interstial Lung Disease (ILD)
Complement 3 Glomerulopathy (C3G)

What is Saventic Med?

Saventic Med is a platform designed for hospitals and clinics who want to improve their patient experience by providing faster and more accurate rare disease diagnosis. The implementation process takes 4-6 weeks and happens in place, ensuring data protection and safety.

Set Up

We install a local server with our algorithms to scan anonymized patient's data.

Screening

Our algorithms flag patients with high risk of rare diseases, based on EMR information.

Report

Our platform generates a report and, with this information, your medical team can start a diagnostic and treatment plan.

What is Saventic Care?

After visiting many doctors and not getting a final diagnosis, patients and their families often start looking for answers on their own. This is why we created an online platform where they can assess the risk of rare diseases and receive personalized guidance on where to find the right support.

Online Form

Patients inform their symptoms, medical history and previous test results.

Analysis

After scanning patients’ data, our algorithms flag the ones with high risk of rare diseases.

Feedback

Our medical team checks the risk and we share with the patient their orientations.

Publications

Supporting the Diagnosis of Fabry Disease Using a Natural Language Processing-Based Approach

An NLP-based scoring system was developed to identify Fabry disease using electronic health records. It showed high accuracy (AUC 0.998) and successfully flagged a confirmed case, supporting earlier and more precise diagnosis.

Artificial Intelligence-Based Algorithm for the Diagnosis of Idiopathic Multicentric Castleman's Disease in a Lower-Middle Income Country

Idiopathic multicentric Castleman's disease (iMCD) is an ultra-rare condition often diagnosed late due to low awareness. An AI-based algorithm using electronic health records may help detect suspected cases that were previously overlooked.